Mark P. Connolly

2.1k total citations
120 papers, 1.4k citations indexed

About

Mark P. Connolly is a scholar working on Economics and Econometrics, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mark P. Connolly has authored 120 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Economics and Econometrics, 22 papers in Epidemiology and 21 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mark P. Connolly's work include Health Systems, Economic Evaluations, Quality of Life (23 papers), Assisted Reproductive Technology and Twin Pregnancy (17 papers) and Reproductive Health and Technologies (15 papers). Mark P. Connolly is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (23 papers), Assisted Reproductive Technology and Twin Pregnancy (17 papers) and Reproductive Health and Technologies (15 papers). Mark P. Connolly collaborates with scholars based in Netherlands, United Kingdom and United States. Mark P. Connolly's co-authors include Maarten J. Postma, Stijn Hoorens, Georgina Chambers, Aomesh Bhatt, William J. Ledger, Baudouin Standaert, Craig J. Currie, F. Bissonnette, Maria P. Vélez and Isaac Jacques Kadoch and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and FEBS Letters.

In The Last Decade

Mark P. Connolly

108 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark P. Connolly Netherlands 21 397 345 305 237 205 120 1.4k
Sara E. Simonsen United States 23 457 1.2× 170 0.5× 279 0.9× 21 0.1× 665 3.2× 93 1.7k
Ivan Verdenik Slovenia 23 768 1.9× 430 1.2× 238 0.8× 25 0.1× 595 2.9× 166 2.1k
Jat Sandhu Canada 18 264 0.7× 72 0.2× 278 0.9× 72 0.3× 287 1.4× 42 1.5k
Annika Strandell Sweden 29 1.1k 2.9× 1.6k 4.5× 139 0.5× 43 0.2× 1.1k 5.3× 91 3.2k
Sandra Marisa Pelloso Brazil 24 354 0.9× 17 0.0× 387 1.3× 65 0.3× 544 2.7× 218 2.0k
Wendy V. Norman Canada 27 881 2.2× 276 0.8× 225 0.7× 26 0.1× 1.4k 6.9× 163 2.4k
C. Y. Yeung Hong Kong 24 275 0.7× 100 0.3× 624 2.0× 10 0.0× 167 0.8× 62 2.0k
Belavendra Antonisamy India 25 470 1.2× 123 0.4× 209 0.7× 25 0.1× 401 2.0× 93 1.8k
Vyta Senikas Canada 31 1.3k 3.3× 1.1k 3.2× 563 1.8× 35 0.1× 1.3k 6.5× 87 3.7k
Jessica Pruszynski United States 17 139 0.4× 42 0.1× 277 0.9× 29 0.1× 302 1.5× 73 1.1k

Countries citing papers authored by Mark P. Connolly

Since Specialization
Citations

This map shows the geographic impact of Mark P. Connolly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark P. Connolly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark P. Connolly more than expected).

Fields of papers citing papers by Mark P. Connolly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark P. Connolly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark P. Connolly. The network helps show where Mark P. Connolly may publish in the future.

Co-authorship network of co-authors of Mark P. Connolly

This figure shows the co-authorship network connecting the top 25 collaborators of Mark P. Connolly. A scholar is included among the top collaborators of Mark P. Connolly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark P. Connolly. Mark P. Connolly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jarrett, James, et al.. (2025). Evaluating the Fiscal Impact of Antiretroviral Therapy for the Management of HIV in the United States 1987–2023. ClinicoEconomics and Outcomes Research. Volume 17. 407–418.
2.
Connolly, Mark P., et al.. (2025). Estimating the Fiscal Value of Children Conceived from Assisted Reproduction Technology in Australia Applying a Public Economic Perspective. Journal of health economics and outcomes research. 12(1). 148–154. 1 indexed citations
3.
Connolly, Mark P., et al.. (2025). Increasing HPV vaccination coverage in Switzerland: a return-on-investment analysis. Journal of Medical Economics. 28(1). 1168–1182.
4.
Bento‐Abreu, André, et al.. (2024). Fiscal analysis of the pediatric immunization program in Belgium applying a lifetime government perspective framework. Expert Review of Pharmacoeconomics & Outcomes Research. 24(3). 437–445. 1 indexed citations
5.
Standaert, Baudouin, et al.. (2024). The Knowledge and Application of Economics in Healthcare in a High-Income Country Today: The Case of Belgium. SHILAP Revista de lepidopterología. 12(3). 264–279.
6.
7.
Connolly, Mark P., et al.. (2022). The public economic burden of suboptimal type 2 diabetes control upon taxpayers in Sweden: Looking beyond health costs. Diabetes Obesity and Metabolism. 24(6). 1038–1046. 2 indexed citations
8.
Connolly, Mark P., et al.. (2022). Cost-effectiveness of infant hypoallergenic formulas to manage cow’s milk protein allergy in France. SHILAP Revista de lepidopterología. 11(1). 2154418–2154418. 6 indexed citations
9.
10.
Minshall, Eleanor, et al.. (2021). Cost-effectiveness Analysis of Hypoallergenic Milk Formulas for the Management of Cow’s Milk Protein Allergy in the United Kingdom. Journal of health economics and outcomes research. 8(2). 14–25. 11 indexed citations
11.
Medić, Goran, et al.. (2021). Mobile Cardiac Outpatient Telemetry Patch vs Implantable Loop Recorder in Cryptogenic Stroke Patients in the US – Cost-Minimization Model. Medical Devices Evidence and Research. Volume 14. 445–458. 10 indexed citations
12.
Standaert, Baudouin, Christophe Sauboin, Quentin J. Leclerc, & Mark P. Connolly. (2020). Comparing the Analysis and Results of a Modified Social Accounting Matrix Framework with Conventional Methods of Reporting Indirect Non-Medical Costs. PharmacoEconomics. 39(2). 257–269. 2 indexed citations
13.
Connolly, Mark P., et al.. (2020). <p>Costs Analysis of Fibrin Sealant for Prevention of Anastomotic Leakage in Lower Colorectal Surgery</p>. Risk Management and Healthcare Policy. Volume 13. 5–11. 12 indexed citations
14.
Connolly, Mark P., et al.. (2020). Estimating the government public economic benefits attributed to investing in assisted reproductive technology: a South African case study. SHILAP Revista de lepidopterología. 12. 14–21. 10 indexed citations
15.
Connolly, Mark P., et al.. (2019). Sustainability of public finances: inclusion of unrelated medical cost only part of the story. The European Journal of Health Economics. 20(8). 1281–1282. 1 indexed citations
16.
Connolly, Mark P., et al.. (2019). Estimating the fiscal impact of rare diseases using a public economic framework: a case study applied to hereditary transthyretin-mediated (hATTR) amyloidosis. Orphanet Journal of Rare Diseases. 14(1). 220–220. 13 indexed citations
17.
Connolly, Mark P., et al.. (2019). High burden and low awareness of toxoplasmosis in the United States. Postgraduate Medicine. 131(2). 103–108. 25 indexed citations
18.
Connolly, Mark P., et al.. (2018). Fiscal Impact of Smoking Cessation in Thailand: A Government Perspective Cost-Benefit Analysis. Asia Pacific Journal of Public Health. 30(4). 342–350. 3 indexed citations
19.
Predel, Hans‐Georg, Bruno Giannetti, Mark P. Connolly, Fraser Lewis, & Aomesh Bhatt. (2017). Efficacy and tolerability of a new ibuprofen 200mg plaster in patients with acute sports-related traumatic blunt soft tissue injury/contusion. Postgraduate Medicine. 130(1). 24–31. 8 indexed citations
20.
Connolly, Mark P., Cornelis Boersma, & Bas Oldenburg. (2012). The economics of mesalazine in active ulcerative colitis and maintenance in the Netherlands.. PubMed. 70(6). 272–7. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sara E. Simonsen Breakdown of academic impact, for papers by Ivan Verdenik Breakdown of academic impact, for papers by Jat Sandhu Breakdown of academic impact, for papers by Annika Strandell Breakdown of academic impact, for papers by Sandra Marisa Pelloso Breakdown of academic impact, for papers by Wendy V. Norman Breakdown of academic impact, for papers by C. Y. Yeung Breakdown of academic impact, for papers by Belavendra Antonisamy Breakdown of academic impact, for papers by Vyta Senikas Breakdown of academic impact, for papers by Jessica Pruszynski
Rankless by CCL
2026